Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Antonio L Dans; Stuart J Connolly; Lars Wallentin; Sean Yang; Juliet Nakamya; Martina Brueckmann; Michael Ezekowitz; Jonas Oldgren; John W Eikelboom; Paul A Reilly

doi:10.1161/CIRCULATIONAHA.112.115386

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Identifier:nobleid.org/w1/20260515/C97B48DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C97B48DF.svg?ark=w1%2F20260515%2FC97B48DF)](https://nobleid.org/work/w1/20260515/C97B48DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Identifier:nobleid.org/w1/20260515/C97B48DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C97B48DF.svg?ark=w1%2F20260515%2FC97B48DF)](https://nobleid.org/work/w1/20260515/C97B48DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work